Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
CHARLOTTESVILLE, Va., Feb. 13, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage […]